ALDESLEUKIN for Malignant melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 37 adverse event reports in the FDA FAERS database where ALDESLEUKIN was used for Malignant melanoma.
Most Reported Side Effects for ALDESLEUKIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pyrexia | 112 | 13.5% | 10 | 34 |
| Off label use | 105 | 12.6% | 4 | 27 |
| Pain | 76 | 9.2% | 1 | 16 |
| Hypotension | 62 | 7.5% | 18 | 37 |
| Drug ineffective | 53 | 6.4% | 3 | 19 |
| Thrombocytopenia | 52 | 6.3% | 14 | 29 |
| Hypoxia | 47 | 5.7% | 17 | 32 |
| Fatigue | 46 | 5.5% | 7 | 16 |
| Chills | 45 | 5.4% | 6 | 20 |
| Acute kidney injury | 41 | 4.9% | 12 | 36 |
| Febrile neutropenia | 41 | 4.9% | 4 | 15 |
| Cardiotoxicity | 40 | 4.8% | 2 | 3 |
| Nausea | 38 | 4.6% | 9 | 15 |
| Pancytopenia | 38 | 4.6% | 6 | 29 |
| Anaemia | 35 | 4.2% | 3 | 14 |
Other Indications for ALDESLEUKIN
Neuroblastoma (146)
Metastatic malignant melanoma (137)
Product used for unknown indication (115)
Neoplasm (23)
Acute myeloid leukaemia (21)
Graft versus host disease (21)
Non-small cell lung cancer (20)
Renal cell carcinoma (18)
Metastatic renal cell carcinoma (17)
Interleukin therapy (16)
Other Drugs Used for Malignant melanoma
NIVOLUMAB (10,599)
IPILIMUMAB (8,903)
DABRAFENIB (5,277)
TRAMETINIB DIMETHYL SULFOXIDE (3,841)
PEMBROLIZUMAB (3,261)
BINIMETINIB (2,613)
ENCORAFENIB (2,591)
VEMURAFENIB (2,548)
TRAMETINIB (1,448)
COBIMETINIB (1,324)